Cengild Medical Berhad (0243) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Cengild Medical Berhad (0243) has a cash flow conversion efficiency ratio of -0.001x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (RM-79.00K ≈ $-19.83K USD) by net assets (RM115.87 Million ≈ $29.09 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 0243 stock market capitalisation for the company's overall valuation and market capitalisation.
Cengild Medical Berhad - Cash Flow Conversion Efficiency Trend (2020–2025)
This chart illustrates how Cengild Medical Berhad's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Cengild Medical Berhad Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cengild Medical Berhad ranked by their cash flow conversion efficiency. Explore 0243 cash flow quality score to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Diginex Limited Ordinary Shares
NASDAQ:DGNX
|
-0.503x |
|
Grupo Pochteca S.A.B. de C.V
MX:POCHTECB
|
-0.210x |
|
Globe Metals & Mining Ltd
AU:GBE
|
-0.036x |
|
Wha Yu Industrial Co Ltd
TW:3419
|
-0.083x |
|
Molinos Juan Semino SA
BA:SEMI
|
0.001x |
|
S H L Telemedicine Ltd
SW:SHLTN
|
0.014x |
|
Marti Otel Isletmeleri AS
IS:MARTI
|
-0.004x |
|
Cryosite Ltd
AU:CTE
|
0.361x |
Annual Cash Flow Conversion Efficiency for Cengild Medical Berhad (2020–2025)
The table below shows the annual cash flow conversion efficiency of Cengild Medical Berhad from 2020 to 2025. View 0243 live share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | RM114.46 Million ≈ $28.74 Million |
RM16.08 Million ≈ $4.04 Million |
0.140x | +20.87% |
| 2024-06-30 | RM111.30 Million ≈ $27.94 Million |
RM12.94 Million ≈ $3.25 Million |
0.116x | -10.39% |
| 2023-06-30 | RM106.11 Million ≈ $26.64 Million |
RM13.76 Million ≈ $3.46 Million |
0.130x | -14.22% |
| 2022-06-30 | RM92.95 Million ≈ $23.34 Million |
RM14.05 Million ≈ $3.53 Million |
0.151x | -85.43% |
| 2021-06-30 | RM13.78 Million ≈ $3.46 Million |
RM14.30 Million ≈ $3.59 Million |
1.038x | -9.62% |
| 2020-06-30 | RM9.79 Million ≈ $2.46 Million |
RM11.24 Million ≈ $2.82 Million |
1.148x | -- |
About Cengild Medical Berhad
Cengild Medical Berhad, an investment holding company, operates a medical center in Malaysia. The company offers various care and treatment consultant services for gastrointestinal and liver diseases, morbid obesity, and oncology and urological conditions; general cardiology and gynecology assessment; gastroenterology and hepatology; anesthesiology, general surgery, internal medicine, and radiolo… Read more